Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Genes · 04.02.2023 · 14 (2) · 407
DOI: 10.3390/genes14020407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 04.02.2023. Verfasst von Luis Daniel González-Vázquez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center (CINBIO), University of Vigo, 36310 Vigo, Spain. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness.
Abstract (Originalsprache)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produced diverse molecular variants during its recent expansion in humans that caused different transmissibility and severity of the associated disease as well as resistance to monoclonal antibodies and polyclonal sera, among other treatments. In order to understand the causes and consequences of the observed SARS-CoV-2 molecular diversity, a variety of recent studies investigated the molecular evolution of this virus during its expansion in humans. In general, this virus evolves with a moderate rate of evolution, in the order of 10−3–10−4 substitutions per site and per year, which presents continuous fluctuations over time. Despite its origin being frequently associated with recombination events between related coronaviruses, little evidence of recombination was detected, and it was mostly located in the spike coding region. Molecular adaptation is heterogeneous among SARS-CoV-2 genes. Although most of the genes evolved under purifying selection, several genes showed genetic signatures of diversifying selection, including a number of positively selected sites that affect proteins relevant for the virus replication. Here, we review current knowledge about the molecular evolution of SARS-CoV-2 in humans, including the emergence and establishment of variants of concern. We also clarify relationships between the nomenclatures of SARS-CoV-2 lineages. We conclude that the molecular evolution of this virus should be monitored over time for predicting relevant phenotypic consequences and designing future efficient treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Research Center (CINBIO), University of Vigo, 36310 Vigo, Spain.
- Department of Biochemistry, Genetics and Immunology, University of Vigo, 36310 Vigo, Spain.
- Galicia Sur Health Research Institute (IIS Galicia Sur), 36310 Vigo, Spain.
ORCID-Profile: Miguel Arenas
Förderung
- Spanish Ministry of Economy and Competitiveness
Zitieren
APA
González-Vázquez, L. D., & Arenas, M. (2023). Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic. Genes, 14(2), 407. https://doi.org/10.3390/genes14020407
Vancouver
González-Vázquez LD, Arenas M. Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic. Genes. 2023;14(2):407. doi:10.3390/genes14020407
BibTeX
@article{GonzlezVzquez2023,
author = {González-Vázquez, Luis Daniel and Arenas, Miguel},
title = {Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic},
journal = {Genes},
year = {2023},
volume = {14},
number = {2},
pages = {407},
doi = {10.3390/genes14020407}
}
EUVIMED